Dopamine Agonist Monitoring


By Belinda Kessel, Parkinson's Specialist and Geriatrician, Princess Royal Hospital, University Hospital Farnborough

Background

  • Increasing use of Dopamine Agonists within PD patients
  • Increasing awareness of potential side effects
  • Increasing recommendations by drug companies and BNF on monitoring
Dopamine Agonist Monitoring

More Parkinson's Academy Medication Projects

Assessment of Rotigotine patch in Parkinson’s disease patients
By Dr Shital Shah, Consultant Physician, Frimley Health NHS Foundation Trust
Parkinson's Disease Acute Admissions Medication Audit
By Dr James Shaw, Specialist Registrar, Perth Royal Infirmary
Audit of ICD documentation in patients receiving Dopamine agonists
By Dr Alagaratnam Niruban, Consulant Geriatrician & Dr Indunil Gunawardena, Consultant MFE, Norfolk & Norwich NHS Trust
'The things you can't get from the books'

Parkinson's Academy, our original and longest running Academy, houses 19 years of inspirational projects, resources, and evidence for improving outcomes for people with Parkinson's. Led by co-founder and educational director Dr Peter Fletcher, the Academy has a truly collegiate feel and prides itself on delivering 'the things you can't get from books' - a practical learning model which inspires all Neurology Academy courses.